Enhancing the antimalarial activity of artesunate

被引:44
作者
Adebayo, J. O. [1 ]
Tijjani, H. [2 ]
Adegunloye, A. P. [1 ]
Ishola, A. A. [1 ]
Balogun, E. A. [1 ]
Malomo, S. O. [1 ]
机构
[1] Univ Ilorin, Fac Life Sci, Dept Biochem, Ilorin, Nigeria
[2] Bauchi State Univ, Dept Biochem, Gadau, Bauchi State, Nigeria
关键词
Artesunate; Combination therapy; Hybrids; Enhanced activity; Malaria; PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; ARTEMISININ-DERIVED DIMERS; ANTIPLASMODIAL ACTIVITY; IN-VITRO; DRUG RESISTANCE; ATOVAQUONE-PROGUANIL; AFRICAN CHILDREN; PHARMACOKINETICS; MEFLOQUINE;
D O I
10.1007/s00436-020-06786-1
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The global challenge to the treatment of malaria is mainly the occurrence of resistance of malaria parasites to conventionally used antimalarials. Artesunate, a semisynthetic artemisinin compound, and other artemisinin derivatives are currently used in combination with selected active antimalarial drugs in order to prevent or delay the emergence of resistance to artemisinin derivatives. Several methods, such as preparation of hybrid compounds, combination therapy, chemical modification and the use of synthetic materials to enhance solubility and delivery of artesunate, have been employed over the years to improve the antimalarial activity of artesunate. Each of these methods has advantages it bestows on the efficacy of artesunate. This review discussed the various methods employed in enhancing the antimalarial activity of artesunate and delaying the emergence of resistance of parasite to it.
引用
收藏
页码:2749 / 2764
页数:16
相关论文
共 143 条
[1]   Evaluation of the antiplasmodial and cytotoxicity potentials of husk fiber extracts from Cocos nucifera, a medicinal plant used in Nigeria to treat human malaria [J].
Adebayo, J. O. ;
Santana, A. E. G. ;
Krettli, A. U. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2012, 31 (03) :244-249
[2]   Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children:: a randomised, multicentre trial [J].
Adjuik, M ;
Agnamey, P ;
Babiker, A ;
Borrmann, S ;
Brasseur, P ;
Cisse, M ;
Cobelens, F ;
Diallo, S ;
Faucher, JF ;
Garner, P ;
Gikunda, S ;
Kremsner, PG ;
Krishna, S ;
Lell, B ;
Loolpapit, M ;
Matsiegui, PB ;
Missinou, MA ;
Mwanza, J ;
Ntoumi, F ;
Olliaro, P ;
Osimbo, P ;
Rezbach, P ;
Some, E ;
Taylor, WRJ .
LANCET, 2002, 359 (9315) :1365-1372
[3]   Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance [J].
Amolegbe, Saliu Alao ;
Hirano, Yui ;
Adebayo, Joseph Oluwatope ;
Ademowo, Olusegun George ;
Balogun, Elizabeth Abidemi ;
Obaleye, Joshua Ayoola ;
Krettli, Antoniana Ursine ;
Yu, Chengzhong ;
Hayami, Shinya .
SCIENTIFIC REPORTS, 2018, 8
[4]  
[Anonymous], 1980, Yao Xue Xue Bao, V15, P630
[5]  
[Anonymous], 2017, ANN PHARM PHARM
[6]  
[Anonymous], 2018, Depression
[7]  
[Anonymous], 2014, INT J PHARM PHARM SC
[8]  
[Anonymous], 2007, WHA60/2007/REC/1
[9]  
[Anonymous], 2012, MAL POL ADV COMM M W
[10]  
[Anonymous], 2010, WHO GUIDELINES TREAT